A novel therapeutic eradicates gastric cancer in treated mice. A novel therapeutic eradicates gastric cancer
Key Highlights :
1. A novel cancer therapeutic, combining antibody fragments with molecularly engineered nanoparticles, permanently eradicated gastric cancer in treated mice.
2. The results of the therapy were the culmination of more than five years of collaboration between Cornell, the Memorial Sloan Kettering Cancer Center (MSKCC) and biopharmaceutical company AstraZeneca.
3. The therapy is an evolution of what the researchers call Cornell prime dots, or C' dots.
4. The therapy is small enough to penetrate tumors and safely pass through organs once injected into the body.
5. The research behind the new C' dot therapeutic will be continued by Elucida Oncology, a startup company founded by Wiesner and Bradbury.
A novel cancer therapeutic combining antibody fragments with molecularly engineered nanoparticles permanently eradicated gastric cancer in treated mice.
Continue Reading at Source : news-medical
